Market Place
Sourcing Support
Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd.
19 Aug 2024 //
GLOBENEWSWIRE
Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria
25 Jan 2024 //
GLOBENEWSWIRE
Titan Pharmaceuticals Announces Reverse Stock Split and Ratio
28 Dec 2023 //
GLOBENEWSWIRE
Titan Appointed Dato` Seow Gim Shen and Brynner Chaim to Board of Directors
16 Oct 2023 //
GLOBENEWSWIRE
Titan Announces $9.5 Million Private Placement of Convertible Preferred Stock
18 Sep 2023 //
GLOBENEWSWIRE
Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets
27 Jul 2023 //
GLOBENEWSWIRE
Titan Pharmaceuticals Provides Shareholder Update
15 Dec 2022 //
GLOBENEWSWIRE
Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular
12 Dec 2022 //
GLOBENEWSWIRE
Titan Pharmaceuticals Announces Board Expansion and Management Changes
16 Aug 2022 //
PRNEWSWIRE
FDA Clears Titan`s IND Application for Nalmefene Implant
05 Jul 2022 //
PRNEWSWIRE
Titan Pharma Announces Pricing of $5.5M Registered Direct and PIPE Offering
02 Feb 2022 //
PRNEWSWIRE
Titan Receives Funds for Combination HIV Therapeutic and Contraceptive Implant
25 Oct 2021 //
PRNEWSWIRE
Titan and MUSC FRD Enter Into Research and Option License Agreement
12 Oct 2021 //
PRNEWSWIRE
Titan Announces Positive Results from the First Studies of TP-2021 Implant
23 Jun 2021 //
PRNEWSWIRE
Positive Early Study Results Help Pave Wave for Titan Pharmaceuticals to Move
01 Feb 2021 //
PRNEWSWIRE
Titan Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements
16 Dec 2020 //
PRNEWSWIRE
Titan Pharmaceuticals, Idera Pharmaceuticals leads healthcare gainers
20 Nov 2020 //
SEEKING ALPHA
Titan Enters Into Definitive Agreement To Acquire JT Pharma`s Peptide, JT-09
28 Oct 2020 //
BIOSPACE
Titan Enters Into Agreement To Acquire JT Pharma`s Kappa Peptide, JT-09
28 Oct 2020 //
PRNEWSWIRE
Titan Announces Debt Settlement Agreement with Molteni and Horizon
26 Oct 2020 //
PRNEWSWIRE
Titan Announces Debt Settlement Agreement with Molteni and Horizon
26 Oct 2020 //
PRNEWSWIRE
Titan Pharma Announces Pricing of $2.7 Million Registered Direct Offering
24 Sep 2020 //
PRNEWSWIRE
Titan Pharmaceuticals` Stockholders Approve Proposal To its Certificate Of Inc
18 Sep 2020 //
BIOSPACE
Molteni, Enters Into European Distribution Agreement With Accord Healthcare
15 Sep 2020 //
PRESS RELEASE
Titan Urges Stockholders to Vote "FOR" Proposal to Amend Its Certificate
08 Jul 2020 //
PRNEWSWIRE
Titan And Indegene Enter Into Probuphine® Co-Promotion Partnership
24 Jun 2020 //
PRNEWSWIRE
Titan Pharmaceuticals Appoints Dr. Kate DeVarney To Its Board Of Directors
31 Dec 2019 //
PR NEWSWIRE
US FDA approves Janssen`s Erleada for castration-sensitive prostate cancer
20 Sep 2019 //
PHARMABIZ
Titan Announces Pricing Of $2.1 M Registered Direct Offering
07 Aug 2019 //
PR NEWSWIRE
Titan Pharmaceuticals Partners With Southside
04 Jun 2019 //
PR NEWSWIRE
Titan Further Expands Patient Access To Probuphine® Via Product
13 May 2019 //
PR NEWSWIRE
Titan Pharmaceuticals Reports Positive Initial Results Of Probuphine® Relaunch
31 Jan 2019 //
PR NEWSWIRE
Titan Awarded NIDA Grant For Nalmefene Implant against Opioid Addiction Relapse
10 Sep 2018 //
PR NEWSWIRE
Titan Executes Agreement For Acquisition By Molteni Of Probuphine® In Europe And Other Select Territories
21 Mar 2018 //
PR NEWSWIRE
